about
Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer.COX-2 overexpression increases malignant potential of human glioma cells through Id1.Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.Childhood intracranial ependymoma: twenty-year experience from a single institution.Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control.Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionationApplication of metabolic PET imaging in radiation oncology.Comparing central nervous system (CNS) and extra-CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program: analysis of 655 patients and review of current literature.Quantitative tumor segmentation for evaluation of extent of glioblastoma resection to facilitate multisite clinical trials.Improved hippocampal dose with reduced margin radiotherapy for glioblastoma multiforme.Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults.Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy.Progesterone improves neurocognitive outcomes following therapeutic cranial irradiation in mice.Immunohistochemical demonstration of isocitrate dehydrogenase 1 (IDH1) mutation in a small subset of prostatic carcinomas.In regard to Roberge et al.Transient enlargement of craniopharyngioma after radiation therapy: pattern of magnetic resonance imaging response following radiation.Automated population-based planning for whole brain radiation therapy.Patterns of presentation and failure in patients with gliomatosis cerebri treated with partial-brain radiation therapy.Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era.Pseudo CT estimation from MRI using patch-based random forestAssociation of Clinical Response and Long-term Outcome Among Patients With Biopsied Orbital Pseudotumor Receiving Modern Radiation TherapyTesticular Seminoma 16 Years After Treatment for CNS GerminomaTreatment of Pediatric Intracranial Arteriovenous Malformations with Linear-Accelerator-Based Stereotactic Radiosurgery: The University of Pennsylvania ExperienceIn vitro and in vivo enhancement of chemoradiation using the oral PARP inhibitor ABT-888 in colorectal cancer cellsMetastasis infiltration: an investigation of the postoperative brain-tumor interfaceA Surveillance, Epidemiology and End Results (SEER) program comparison of adult and pediatric Wilms' tumorReduced-volume tumor-bed boost is not associated with inferior local control and survival outcomes in high-risk medulloblastoma
P50
Q30650896-769A666D-3A51-4286-BA87-F0A9B9BE48BCQ33576867-106056EC-9692-4185-8C45-8212F71A387EQ34054134-6F9AE843-8543-4DB8-B0E4-327BCB6DB213Q35006946-A950B437-0489-4E96-A8D4-CE33010929C1Q35091200-E0DF3898-93F5-43CB-97C5-F31520245AE2Q36845058-EB98B7FB-66B8-4FE7-A3CA-FF3C84C202A4Q36850293-AA547154-72AE-4759-8BEF-A7E3269D663BQ36958100-84AAB762-DBA3-414F-AB65-A03031B82DE5Q37580845-7E9602FF-B723-4893-A275-544857207074Q38003904-6A25DA45-8630-4356-AA44-9133E1958C07Q38950093-3CF1A711-D4C2-4E9B-8974-81CC8CE22710Q39275344-7939A280-04F8-41C5-B2C4-2C5955881F63Q40360133-684089D2-2197-43ED-AD34-7025B5FF9B63Q43629767-42D4B2F5-B7E9-4134-8756-1A2BEC051794Q44122158-216B163B-F028-4DBB-ADE8-89568407BFEDQ45076956-6A1CCBA0-B57F-41E1-9BBA-9C680CDDA2C5Q47864608-9674C07B-A36E-41CE-93AD-C379339B6D3DQ48256021-E6A6D039-84E8-4469-B0C9-8B012C2DDD41Q48367580-78A7BE96-7124-460C-851B-ADF60E998B8DQ48475589-2D3D14B6-22D6-4211-A974-041CE6CB4C05Q49108626-7698F1BF-C378-43B0-8673-3BD3AB62D8D2Q55460912-F31F1AF7-26F8-4E35-BD3A-E71939B0CFEFQ55472005-DFC0B55A-2794-4E24-8DA5-14974F4E7A43Q59340941-EB2771A4-1BBA-4969-8026-146E4B1A4309Q59340958-0EF8BAB0-95D9-450A-A9BB-A0A6084A1DCBQ59340960-87802766-7733-48D5-8149-275F28B52BF4Q59340977-065FCF1A-55C0-461B-A57F-6026900030F5Q64386358-43D2356D-F845-40D2-866F-CD74FD3BF11DQ82032573-F396D442-6233-495B-ABD7-ACB862C1EB85Q84945855-E0A24AB5-49D8-4A6E-918A-6F209BDF717DQ90394864-3119F3E5-4F67-4014-AE6A-14A7987E2DB5
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-4060-0874
@en
name
Hui-Kuo G Shu
@ast
Hui-Kuo G Shu
@en
Hui-Kuo G Shu
@nl
type
label
Hui-Kuo G Shu
@ast
Hui-Kuo G Shu
@en
Hui-Kuo G Shu
@nl
prefLabel
Hui-Kuo G Shu
@ast
Hui-Kuo G Shu
@en
Hui-Kuo G Shu
@nl
P106
P31
P496
0000-0002-4060-0874